{
  "id": 12351,
  "url": "https://arxiv.org/abs/2607.18696v1",
  "title": "Do AI-Native Biotechs Need Departments? Benchmarking Company World Models for AI-Driven Drug Development",
  "summary": "AI-native biotechnology companies are often designed by copying human biotech org charts into agent roles. We argue for a different abstraction: a Company World Model, defined as a persistent asset-to-value state representation with transition models, explicit value functions, planning, and updating across scientific, regulatory, BD, commercial, financial, and execution constraints. We introduce a dry-lab benchmark for testing whether AI-agent organizations should mimic departments or operate ar",
  "authors": "Yinan Wang",
  "category": "research",
  "topics": "regulation,healthcare,agents-autonomy,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2026-07-21T04:34:35.000Z",
  "fetched_at": "2026-07-22T05:10:49.469Z",
  "source_slug": "arxiv-ethics",
  "source_name": "arXiv",
  "source_homepage": "https://arxiv.org",
  "ethics_ai_record_url": "https://ethics.ai/record/12351",
  "original_url": "https://arxiv.org/abs/2607.18696v1",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}